Literature DB >> 24723679

Id2 represses E2A-mediated activation of IL-10 expression in T cells.

Frederick Masson1, Margherita Ghisi2, Joanna R Groom1, Axel Kallies1, Cyril Seillet1, Ricky W Johnstone3, Stephen L Nutt1, Gabrielle T Belz1.   

Abstract

Interleukin-10 (IL-10) is a key immunoregulatory cytokine that functions to prevent inflammatory and autoimmune diseases. Despite the critical role for IL-10 produced by effector CD8(+) T cells during pathogen infection and autoimmunity, the mechanisms regulating its production are poorly understood. We show that loss of the inhibitor of DNA binding 2 (Id2) in T cells resulted in aberrant IL-10 expression in vitro and in vivo during influenza virus infection and in a model of acute graft-versus-host disease (GVHD). Furthermore, IL-10 overproduction substantially reduced the immunopathology associated with GVHD. We demonstrate that Id2 acts to repress the E2A-mediated trans-activation of the Il10 locus. Collectively, our findings uncover a key regulatory role of Id2 during effector T cell differentiation necessary to limit IL-10 production by activated T cells and minimize their suppressive activity during the effector phase of disease control.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24723679     DOI: 10.1182/blood-2014-03-561456

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Stages versus subsets: Invariant Natural Killer T cell lineage differentiation.

Authors:  Heather M Buechel; Martin H Stradner; Louise M D'Cruz
Journal:  Cytokine       Date:  2015-01-31       Impact factor: 3.861

2.  All work and no Id2 makes a dull NKT cell.

Authors:  Daniel G Pellicci; Adam P Uldrich
Journal:  Immunol Cell Biol       Date:  2016-05-03       Impact factor: 5.126

3.  The Transcriptional Regulator Id2 Is Critical for Adipose-Resident Regulatory T Cell Differentiation, Survival, and Function.

Authors:  Adolfo B Frias; Eric J Hyzny; Heather M Buechel; Lisa Y Beppu; Bingxian Xie; Michael J Jurczak; Louise M D'Cruz
Journal:  J Immunol       Date:  2019-06-14       Impact factor: 5.422

4.  A molecular threshold for effector CD8(+) T cell differentiation controlled by transcription factors Blimp-1 and T-bet.

Authors:  Annie Xin; Frederick Masson; Yang Liao; Simon Preston; Tianxia Guan; Renee Gloury; Moshe Olshansky; Jian-Xin Lin; Peng Li; Terence P Speed; Gordon K Smyth; Matthias Ernst; Warren J Leonard; Marc Pellegrini; Susan M Kaech; Stephen L Nutt; Wei Shi; Gabrielle T Belz; Axel Kallies
Journal:  Nat Immunol       Date:  2016-03-07       Impact factor: 25.606

5.  Bypassing STAT3-mediated inhibition of the transcriptional regulator ID2 improves the antitumor efficacy of dendritic cells.

Authors:  Haiyan S Li; Chengwen Liu; Yichuan Xiao; Fuliang Chu; Xiaoxuan Liang; Weiyi Peng; Jianhua Hu; Sattva S Neelapu; Shao-Cong Sun; Patrick Hwu; Stephanie S Watowich
Journal:  Sci Signal       Date:  2016-09-27       Impact factor: 8.192

6.  Id2 regulates hyporesponsive invariant natural killer T cells.

Authors:  Martin H Stradner; Kitty P Cheung; Anna Lasorella; Ananda W Goldrath; Louise M D'Cruz
Journal:  Immunol Cell Biol       Date:  2016-02-16       Impact factor: 5.126

7.  Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease.

Authors:  Victor Tkachev; James Kaminski; E Lake Potter; Scott N Furlan; Alison Yu; Daniel J Hunt; Connor McGuckin; Hengqi Zheng; Lucrezia Colonna; Ulrike Gerdemann; Judith Carlson; Michelle Hoffman; Joe Olvera; Chris English; Audrey Baldessari; Angela Panoskaltsis-Mortari; Benjamin Watkins; Muna Qayed; Yvonne Suessmuth; Kayla Betz; Brandi Bratrude; Amelia Langston; John T Horan; Jose Ordovas-Montanes; Alex K Shalek; Bruce R Blazar; Mario Roederer; Leslie S Kean
Journal:  Sci Transl Med       Date:  2021-01-13       Impact factor: 19.319

8.  Regulatory T cells characterized by low Id3 expression are highly suppressive and accumulate during chronic infection.

Authors:  Katharina S Rauch; Miriam Hils; Alexandra J Menner; Mikael Sigvardsson; Susana Minguet; Peter Aichele; Christian Schachtrup; Kristina Schachtrup
Journal:  Oncotarget       Date:  2017-10-27

Review 9.  The Id-protein family in developmental and cancer-associated pathways.

Authors:  Cornelia Roschger; Chiara Cabrele
Journal:  Cell Commun Signal       Date:  2017-01-25       Impact factor: 5.712

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.